UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Amid plunging Seoul bourse, diagnostic firms enjoy price rise
While the nation's main stock market is showing a historically steep ra...
by Lee Han-soo
|
2020-03-23 17:46
라인
GC MS, Genecast to co-develop COVID-19 detection kit
GC MS and Genecast said they would join forces to develop a new COVID-19 de...
by Lee Han-soo
|
2020-03-23 16:03
라인
Daewoong to market Genomictree's colon cancer diagnostic kit
Genomictree said that Daewoong Pharmaceutical would market and co-sale its ...
by Lee Han-soo
|
2020-03-23 11:59
라인
SK Bioscience starts animal trial of COVID-19 vaccine
SK Bioscience said that it has succeeded in discovering a vaccine candidate...
by Lee Han-soo
|
2020-03-23 11:52
라인
Amid subdued new cases, Korea alert on cluster infections, foreign influxes
Korea recorded new COVID-19 cases below 100 again on Saturday, while seeing...
by Lee Han-soo
|
2020-03-22 12:21
라인
‘Managing Parkinson’s disease gets more elaborate after deep brain stimulation’
Researchers at Seoul National University Hospital have found they can enhan...
by Lee Han-soo
|
2020-03-20 18:09
라인
Korea struggles to secure supply of rare drugs amid COVID-19
Korea Orphan & Essential Drug Center (KOEDC) said that it is having a hard ...
by Lee Han-soo
|
2020-03-20 16:54
라인
Samsung Bioepis’ biosimilar breast cancer treatment scores FDA’s nod
Samsung Bioepis said Friday that the U.S. Food and Drug Administration has ...
by Lee Han-soo
|
2020-03-20 16:52
라인
Optimal third-line therapy found for type 2 diabetes
For type 2 diabetes patients in Korea, thiazolidinedione (TZD) could provid...
by Lee Han-soo
|
2020-03-20 12:34
라인
Macrogen reports profit drop in 2019
Macrogen said that it posted 122.3 billion won ($97.6 million) in sales las...
by Lee Han-soo
|
2020-03-20 12:34
라인
DM Bio, GI Innovation tie up on allergy treatment candidate
DM Bio said that it has made a contract development and manufacture organiz...
by Lee Han-soo
|
2020-03-19 15:54
라인
[Up-and-coming medical startups of 2020] SMD Solution provide full dental care for everyone
SMD Solution is a startup that garnered global attention during the CES 202...
by Lee Han-soo
|
2020-03-19 15:46
라인
AbClon wins US patent for autoimmune bispecific antibody
AbClon said that it has succeeded in obtaining a U.S. patent for the AM201,...
by Lee Han-soo
|
2020-03-19 15:45
라인
Wells Bio to export COVID-19 diagnostic kit
Wells Bio, a subsidiary of Access Bio, said Thursday that it would start ex...
by Lee Han-soo
|
2020-03-19 12:53
라인
Theragen ETEX to develop treatment candidate for COVID-19
Theragen ETEX said that it has found multiple drug candidates for treating ...
by Lee Han-soo
|
2020-03-18 17:41
라인
Kainos Medicine asks FDA to meet on Parkinsonism treatment
Kainos Medicine said that it has made a request to the U.S. Food and Drug A...
by Lee Han-soo
|
2020-03-18 17:07
라인
SNUBH releases treatment details of 1st pediatric COVID-19 patient
A group of researchers at Seoul National University Bundang Hospital (SNUBH...
by Lee Han-soo
|
2020-03-18 12:56
라인
AI service for quick COVID-19 diagnosis to debut this month
Myongji Hospital said that it is working with PhenoMX to develop an artific...
by Lee Han-soo
|
2020-03-18 12:55
라인
[Up-and-coming medical startups of 2020] Huinno to prove digital healthcare’s potential with 1st wearable ECG device
Huinno CEO Gil Yeong-joon explains the benefits of his company’s new device...
by Lee Han-soo
|
2020-03-18 12:15
라인
Samsung Biologics makes CDO partnership with Taiwanese bio-venture
Samsung Biologics said that it has entered into a contract developing organ...
by Lee Han-soo
|
2020-03-17 17:31
-
이전
11
12
13
14
15
16
17
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top